Friday, 6th May 2011 / Venue: Conference Hall 2, Level 3

PLENARY 1 HEART FAILURE 1

08:00 0!:00
Chair"er#on#: $i% &ui Hian 'M() / *+ira Mat#u%ori ',-)
-1.1 -o#t *M/ re%odellin0: %echani#% of action
1o2erto Ferrari '/3)
-1.2 Heart Failure 4ith "re#erved 5F
Michel &o%ad6a 'F1)
SYMPOSIUM 7 HEART FAILURE 2: PREVENTING PROGRESSION TO HEART
FAILURE
0!:00 10:30
Chair"er#on#: 5un $eo+ ,eun '&1) / $iti &hairani 'M()
$7.1 -o#t M/ and *#y%"to%atic LV 8y#function to Heart Failure
Fran# Van de 9erf
$7.2 Coronary *rtery 8i#ea#e and 8y#li"ide%ia to Heart Failure
:ur+urnai (u#of 'M()
$7.3 Hy"erten#ion, Left Ventricular Hy"ertro"hy and 8ia#tolic 8y#function
3hierry ;ille2ert
SYMPOSIUM 47 JOINT SYMPOSIUM 6 - CSC@APSC2011: QUALITY CARE
INITIATIVE IN CARDIOVASCULAR DISEASE
11:00 12:30
Chair"er#on#: Hu 8ayi 'C<) /Huo (on0 'C<) / *lan Fon0 'M()
$=7.1 3ar0eted ca#e findin0 for cardiova#cular "revention
:han0 9ei :hon0 'C<)
$=7.2 /%"rovin0 facilitie# for $35M/ "atient# receivin0 re"erfu#ion thera"y
Huo (on0 'C<)
$=7.3 -erfor%ance i%"rove%ent in the care of atrial fi2rillation "atient#
8u >in 'C<)
$=7.= 8i#cu##ion
SYMPOSIUM 1 SPECIAL LECTURE 1: HYRID PROCEDURE
1=:00 1?:30
Chair"er#on#: 1yu6i <ohari ',-) / *nuar Ma#du+i 'M()
$1.1 8e#i0n of Hy2rid Catheri@ation La2, &ey# to $ucce##
1alf Hol@er 'A$)
$1.2 B2tainin0 the Ce#t of the 34o 9orld# . Cardiolo0i#t -er#"ective
;oran $tan+ovic '$;)
$1.3 Hy2rid Coronary 1eva#culari@ation . 3he Heart $ur0eonD# -er#"ective
Mohd *l4i (unu# 'M()
HO! TO SESSION " PREVENTIVE CARDIOLOGY 6: HO! TO EFFECTIVELY
MANAGE ASIAN DIAETICS
17:30 18:30
Chair"er#on#: ,uliana Chan 'H&) / &halid &adir 'M()
H3?.1 Ho4 to B"ti%ally %ana0e * <e4ly 8ia0no#ed 8ia2etic -atient
Chan $ie4 -hen0 'M()
H3?.2 Ho4 to -revent and 8elay 8ia2etic 1enal 8i#ea#e
-aola Fioretto '/3)
H3?.3 Ho4 to %ana0e -redia2ete#
3ai 5e $hyon0 '$;)
Friday, 6th May 2011 / Venue: CanEuet Hall, Level 3
PLENARY # CARDIAC IMAGING 1: ROLE OF MULTIMODALITY CARDIAC
IMAGING IN CAD $ NE! INSIGHTS
08:00 0!:00
Chair"er#on#: 3& Bn0 '&1) / 9an &i% '&1)
-3.1 5chocardio0ra"hy
Fau#to -into '-3)
-3.2 Cardiac M1
5i+e <a0el '85)
-3.3 Cardiac C3
$a%uel 9ann
-3.= <uclear Cardiolo0y
SYMPOSIUM 2 ARRHYTHMIA 1: ATRIAL FIRILLATION
0!:00 10:30
Chair"er#on#: Cal2ir $in0h '/<) / $irin *"iya#a4at '3H)
$2.1 Ceyond 1ate and 1hyth% Control
;re0ory Li" 'A&)
$2.2 Catheter *2lation for *F 8efinin0 the #trate0y
3eo 9ee $ion0 '$;)
$2.3 *nticoa0ulation $trate0ie#: Bld and <e4
;re0ory Li" 'A&)
SYMPOSIUM 4 CARDIAC IMAGING 2: !HERE CMR MA%ES A DIFFERENCE
IN THE MANAGEMENT OF CORONARY ARTERY DISEASE
11:00 12:30
Chair"er#on#: $an6iv ,o#hi / *lan Fon0
$=.1 CM1 in Mana0e%ent of Che#t -ain
$te"hen Harden 'A&)
$=.2 1ole of CM1 in Mana0in0 -atient# 4ith &no4n Coronary *rtery 8i#ea#e
*nnuar 1a"aee 'M()
$=.3 Coronary M1*: Current $tatu# *nd Future -er#"ective
5i+e <a0el '85)
C*(51 $*35LL/35 LA<CH $(M-B$/AM
STRO%E PREVENTION FOR PATIENTS !ITH ATRIAL FIRILLATION $
CHALLENGES AND NE! APPROACHES
12:30 12:3? 9elco%e F /ntroduction
$i% &ui Hian 'M()
12:3? 12:?? $tro+e -revention in *trial Fi2rillation '$-*F) &ey i##ue# for
effective %ana0e%ent, 4ith focu# on the *#ia.-acific
re0ion
;re0ory ( H Li" 'A&)
12:?? 13:10 Clinical 1evie4. oral anticoa0ulant# in $-*F %ana0e%ent
3an 1u $an '$;)
13:10 13:3? Movin0 clo#er to a %ore #ucce##ful $-*F %ana0e%ent 4ith
1ivaroGa2an
,ohn -aolini 'A$)
13:3? 13:?0 Ca#e Ca#ed 8i#cu##ion# ne4 oral anticoa0ulant thera"y in *F
3an 1u $an '$;)
13:?0 1=:00 8i#cu##ion F $u%%ary
$i% &ui Hian 'M()
SYMPOSIUM 46 JOINT SYMPOSIUM ": STRO%E PREVENTION IN ATRIAL
FIRILLATION $ A CALL TO ACTION: FOCUS ON THE ASIA-PACIFIC REGION
1=:00 1?:30
Chair"er#on#: $i% &ui Hian 'M() / ;re0ory (H Li" 'A&)
$=6.1 Curden of atrial fi2rillation and #tro+e focu# on the *#ia.-acific re0ion
8avid Hue+ 'M()
$=6.2 3reat%ent #trate0ie# for #tro+e "revention in atrial fi2rillation: 4hat do the
0uideline# #ay and are they adhered toI
8ayi Hu 'C<)
$=6.3 3he "atient "er#"ective
8eirdre Lane 'A&)
$=6.= * Call to *ction
$hinya ;oto ',-)
-anel 8i#cu##ion
HO! TO SESSION 2 ARRHYTHMIA #
17:30 18:30
Chair"er#on#: *@lan Hu##in 'M() / Muha%%ad (a%in '/8)
H32.1 1eadin0 5C; 4ith the %a#ter#
-re#enter#:
1) Mohan <air '/<)
2) :ahid *#la% *4an '-&)
3) Ma $oot &en0
=) $atchana -u%"rue0
-aneli#t:
1) Cal2ir $in0h '/<)
2) $irin *"iya#a4at '3H)
3) CJ <ara#i%han '/<)
Friday, 6th May 2011 / Venue: Callroo% 1, Level 3
SYMPOSIUM # HYPERTENSION 1: P MONITORING $ !HICH IS THE !AY
FOR!ARD&
0!:00 10:30
Chair"er#on#: 1a#hid *2dul 1ah%an / -ar+ ,eun0 Cae '&1)
$3.1 Ho%e C- Monitorin0 Can it /%"rove C- ControlI
&i% 'C/) / *@ani
$3.2 Central *ortic Clood -re##ure Monitorin0 9hat i# the 5videnceI
Cryan 9illia%# 'A&)
$3.3 5%er0in0 *#"ect# of 8ia2ete# and Hy"ertention
Fran@ Me##erli
SYMPOSIUM " MYOCARDIAL ISCHAEMIA 1: UA-NSTEMI
11:00 12:30
Chair"er#on#: 9$ $anthara6 'L&) / B%ar /#%ail 'M()
$?.1 Cardiac Cio%ar+er#: $tate of the art
$idney $%ith 'A$)
$?.2 1i#+ #tratification in A*.<$35M/
,eya%alar 1a6adurai 'M()
$?.3 *nti."latelet thera"y in *C$
-aul Lan0ton '*A)
SYMPOSIUM ' CARDIAC REHAILITATION 1: %EEPING THE CARDIAC
REHAILITATION AGENDA RELEVANT
1=:00 1?:30
Chair"er#on#: *i@ai *@an ' M( ) / *ntonio $i2ulo ' -H )
$8.1 Cardiac 1eha2ilitation *# * 3reat%ent Modality: 9hat /# 3he Current
5videnceI
Leandro Con0o#ia '-H)
$8.2 5Gerci#e 3e#tin0 and -re#cri"tion /n Cardiac 1eha2ilitation: Clinical *nd
-ractical Con#ideration#
Vi#al &antaratana+ul '3H)
$8.3 1eva%"in0 9ei0ht Lo## Mana0e%ent For Cardiova#cular Health
1o+iah -ende+ 'M() / He4 Fen Lee
HO! TO SESSION 6 PREVENTIVE CARDIOLOGY
17:30 18:30
Chair"er#on#: *@hari / Cryan 9illia%#
H36.1 Ho4 to a##e## CV ri#+ in the daily "ractice
;ary ,ennin0# '*A)
H36.2 Ho4 to a""roach the "atient 4ith la2ile C-
3refor Mor0an '*A)
Friday, 6th May 2011 / Venue: Callroo% 2, Level 3
PLENARY 2 INTERVENTIONAL CARDIOLOGY 1
08:00 0!:00
Chair"er#on#: $i% &ui Hian 'M() / 3hac+ <J <0uyen 'A$*)
-2.1 /nterventional Cardiolo0y 33 (ear after *ndrea# ;ruent@i0
1al"h Crindi# 'A$)
-2.2 Hi#tory of /nterventional Cardiolo0y in *#ia -acific 1e0ion
,un2o ;e 'C<)
SYMPOSIUM 4" SPECIAL LECTURE 2 - REPERFUSION INJURY
0!:00 10:30
Chair"er#on#: 1o#li 'M() / Cu% &ee Hon0 '&1)

$=?.1 Ca#e -re#entation '$lo4/<o 1eflo4 in *C$)
9aheed 'M()
$=?.2 * ne4 decade in re"erfu#ion thera"y : 1ole of Cardiac Cio%ar+er#
3hach <0uyen 'A$)
$=?.3 Mana0e%ent of /#che%ic / 1e"erfu#ion in6ury, Cench to CedJ
8on0.,u Choi '&1)
SYMPOSIUM 6 PREVENTIVE CARDIOLOGY 1: LIPIDOLOGY: LDL-C AND
EYOND
11:00 12:30
Chair"er#on#: &hoo &ah Lin 'M() and and 5leanor * Lo"e# '-H)
$6.1 3ar0et# for 8y#li"ide%ia in -ri%ary and $econdary -revention and the 1ole
of H#.C1-
<athan 9on0 'A$)
$6.2 3ri0lyceride.Lo4erin0 For 1eduction of 1e#idual 1i#+
-aola Fioretto '/3)
$6.3 B"tion# for /ncrea#in0 H8L
$an0.Hon0 Cae+ '&1)
NOVARTIS SATELLITE LUNCH SYMPOSIUM
DIRECT RENIN INHIITOR THE POTENTIAL FOR IMPROVED CARDIO$RENAL
PROTECTION IN PATIENTS !ITH HYPERTENSION AND DIAETES
12:30 1=:00
12:30 B"enin0 re%ar+# 2y chair"er#on
12:=0 Lecture 2y -rofJ 8rJ Han#.Henri+ -arvin0
13:20 HF*
13:30 Clo#in0 1e%ar+#
SYMPOSIUM ( VALVULAR HEART DISEASE 1: INFECTIVE ENDOCARDITIS
1=:00 1?:30
Chair"er#on#: 1ahal / *@hari (a+u2 'M()
$!.1 Challen0e# in the 8ia0no#i# of /5
1ic+ <i#hi%ura 'A$)
$!.2 -ro"hylaGi# and *nti Micro2ial 3hera"y in /5
Mario -anali0an '-H)
$!.3 /ndication for $ur0ery and $ur0ical B"tion#
3a4ee#a+ Chotivatana"on0 '3H)
MERC% SERONO SATELLITE SYMPOSIUM
INSIGHTS ON THE ESH GUIDELINE ON MANAGING HYPERTENSION
16:00 17:30
Chair"er#on: *2dul 1a#hid *2dul 1ah%an 'M()
$"ea+er: -rof 8r Crian 3o%lin#on
HO! TO SESSION 7 INTERVENTIONAL CARDIOLOGY #
17:30 18:30
Chair"er#on#: Mitchell 9 &rucoff 'A$*) / $eon0 ,in Bh '&1)
H310.1 1eadin0 /VA$ 4ith the eG"ert
$han0 Lee '&1)
H310.2 1eadin0 BC3 4ith the eG"ert
$eun0 ,un0 -ar+ '&1)
H310.3 Ho4 / u#e FF1
5ric 5ec+hout
Friday, 6th May 2011 / Venue: Conference Hall 1, Level 3
HO! TO SESSION 1 CARDIAC IMAGING "
17:30 18:30
Chair"er#on#: ;oh 3ec+ H4a 'M() / 9an &i% '&1)
H31.1 Ho4 to 5valuate $tenotic Valve
Fau#to -into '-3)
H31.2 Ho4 to 5valuate 1e0ur0itant Valve
Mani Vannan 'A$)
Friday, 6th May 2011 / Venue: Conference Hall 3, Level 3
AOTT SATELLITE LUNCH SYMPOSIUM
IS NE!ER AL!AYS ETTER&
12:30 1=:00
Chair"er#on: 1o2aayah :a%2ahari 'M()
12:30 . 12:=0 /ntroduction ..3an $ri 1o2aayah '/# ne4er al4ay# 2etterI
12:=0 . 13:00 $tent#, $tent# and %ore $tent#: 9hich 85$ i# the #afe#t in the
%ar+etI
13:00 . 13:20 Cio#ora2le "oly%er and <e4 *lloy#: Can they chan0e the 3reat%ent
*l0orith%#I
13:20 . 13:=0 <o environ%ent i# too challen0in0: Can 9e Choo#e the 1i0ht 85$
for a -articular -atientI * Ca#e #tudy
13:=0 . 13:?? -aneli#t# di#cu##ion
13:?? . 1=:00 Conclu#ion
AYER SATELLITE SYMPOSIUM
16:00 . 17:30
16:00 16:0? 9elco%e F /ntroduction
1a%e#h $in0h Veeriah 'M()
16:0? 16:2? V35 treat%ent F itK# "re#ent day challen0e#
(an0.&i &i% '&1)
16:2? 16:=0 Clinical 1evie4. <e4 develo"%ent# in V35 treat%ent
1o## Ca+er '*A)
16:=0 17:0? 1ivaroGa2an * novel #in0le dru0 a""roach to V35 treat%ent
Chiu &M '39)
17:0? 17:20 Ca#e Ca#ed 8i#cu##ion ne4 oral anticoa0ulant# in V35 treat%ent
1o## Ca+er '*A)
17:20 17:30 8i#cu##ion F $u%%ary
1a%e#h $in0h Veeriah 'M()
HO! TO SESSION # ENDOVASCULAR THERAPEUTICS #
17:30 18:30
Chair"er#on#: -aul &ao '39), (o#hio+i (o+oi ',-)
H33.1 Ho4 3o $tart * -eri"heral /ntervention -ro0ra%%e
3a+aa+i /##hi+i ',-)
H33.2 Ho4 3o 5n#ure * $ucce##ful -eri"heral /ntervention: A#eful 3i"# *nd
3ric+#
<eil $tric+%an 'A$)
H33.3 Ho4 3o 8eal 9ith -eri"heral /ntervention Co%"lication#
$haiful *@%i 'M()
Friday, 6th May 2011 / Venue: -lenary 3heatre, Level 3
HO! TO SESSION 4 INTERVENTIONAL CARDIOLOGY 2
17:30 18:30
Chair"er#on#: *riel 8uran 'A() / $i%on Lo 'M()
H3=.1 Ho4 / do %y ante0rade C3B recanali@ationJ
<aoto /noue ',-)
H3=.2 Ho4 / do %y retro0rade C3B recanali@ationJ
$atoru $u%it#u6i ',-)
Friday, 6th May 2011 / Venue: 1oo% 307.30!, Level 3
MEDISPEC SATELLITE SYMPOSIUM
E)TRACORPOREAL SHOC%!AVE MYOCARDIAL REVASCULARI*ATION:
NE! OPTION THERAPY FOR MYOCARDIAL ISCHEMIA IN CORONARY
ARTERY DISEASE
Chair"er#on: 9an *@%an 9an *h%ad 'M() / *leGander Lind '85)
16:00 . 17:30
16:00 16:0? /ntroduction
9an *@%an 9an *h%ad 'M()
16:0? 16:1? 5Gtracor"oreal #hoc+4ave# a""roach in cardiova#cular %edicine
(uri Vin#hto+ 'A$)
16:1? 16:30 5Gtracor"oreal $hoc+ 9ave Myocardial 1eva#culari@ation '5$M1)
a# a treat%ent %odality in "atient# 4ith refractory an0ina
in Aniver#ity Malaya
:ul Hil%i (aa+o2 'M()
16:30 16:=? 5Gtracor"oreal $hoc+4ave Myocardial 1eva#culari@ation '5$M1): *
<e4 o"tion for "er#i#tent an0ina and it# "otential role in #evere
i#che%ic LV dy#function
$u *nn Locnan '-H)
16:=? 17:00 <e4 treat%ent o"tion for Chronic 3otal Bcclu#ion "atient#
*leGander Lind '85)
17:00 17:1? 5G"erience of utili@in0 5$M1 in *2di 9aluyo Ho#"ital ,a+arta,
/ndone#ia
-ra#etyo *ndriono '/8)
17:1? 17:30 Hue#tion F *n#4er
HO! TO SESSION 10
17:30 18:30
Chair"er#on: *lan Fon0 'M()
H310.1 Ho4 to 8e#i0n and $tart a 1e#earch -ro6ect
<athan 9on0 'A$)

$aturday, 7th May 2011 / Venue: Conference Hall 1, Level 3
HO! TO SESSION ' CARDIAC IMAGING 6: CARDIAC CT
17:30 18:30
Chair"er#on#: Bn0 3ion0 &ia% 'M() / 3an $4ee (a4 '$;)
H38.1 -atient $election and -re"arationJ 8o 9e $till <eed Ceta Cloc+er#I
Manoefri# &a#i% '/8)
H38.2 *""ro"riate u#e of Cardiac C3 4hat do the late#t 0uideline# #ayI
Bn0 3ion0 &ia% 'M()
H38.3 /ntere#tin0 Ca#e 8e%o
$uren 3hurai#in0ha% 'M() / Chan 9ai Lin0 'M() / Haifa 'M()
$aturday, 7th May 2011 / Venue: Conference Hall 2, Level 3
SYMPOSIUM 17 HEART FAILURE 4: HEART FAILURE UPDATE
0!:00 10:30
Chair"er#on#: &i% 5un0 ,u '&1) / Chin $@e -ia4 'M()
$17.1 *dvance# in Medical Mana0e%ent of *cute Heart Failure
Cyun0.Hee Bh '&1)
$17.2 *cute Heart Failure 3he 1ole of Mechanical Circulatory $u""ort
Moha%ed 5@ani MdJ 3ai2 'M()
$17.3 Viral /nfection# in Heart Failure
*+ira Mat#u%ori ',-)
SYMPOSIUM 22 HEART FAILURE ": ADVANCED HEART FAILURE
11:00 12:30
Chair"er#on#: 8avid Che4 'M() / 5un $eo+ ,un '&1)
$22.1 1i0ht Heart Failure
Ca%2an0 Cudi $i#4anto '/8)
$22.2 B"ti%al Medical 3hera"y For *dvance $y#tolic Heart Failure
Michel &o%ad6a 'F1)
$22.3 $election of -atient# for 8evice#./C8/C13
Vincent -aul '*A)
$22.= Lon0 3er% V*8 $u""ort and <e4 Ventricular *##i#t 8evice#
Moha%ed 5@ani MdJ 3ai2 'M()
SYMPOSIUM 27 MEET !ITH THE E)PERTS 1
1=:00 1?:30
$27.1 -ro2le% $olvin0 /n Clinical Cardiolo0y
3hach <0uyen 'A$) / *@hari 1o#%an 'M()
-aneli#t#:
1) 3an <in0
2) Mano6+u%ar 1ohit
3) / Chun0 H#ieh
SYMPOSIUM #2 VASCULAR DISEASE 1
16:00 17:30
Chair"er#on#: (o#hio+i (o+oi ',-) / -aul &ao '39)
$32.1 Ander#tandin0 -V8: 3he Mo#t <e0lected Me%2er of CV8
<eil $tric+%an 'A$)
$32.2 Celo4 +nee intervention
3a+aa+i /##hi+i ',-)
$32.3 Controver#ie# in -eri"heral Va#cular /ntervention
Hai@al Haron &a%ar 'M()
HO! TO SESSION 12 PREVENTIVE CARDIOLOGY 7: HO! TO SET UP
EFFECTIVE PREVENTIVE AND REHA PROGRAMMES
17:30 18:30
Chair"er#on#: B%ar /#%ail 'M() / (oichi ;oto ',-)
H312.1 Ho4 to $tart * Cardiac 1eha2ilitation $ervice /n (our Ho#"ital 'Fro%
$cratchL)
-eter 3in0 '$;)
H312.2 Ho4 to $et A" * -reventive Cardiolo0y -ro0ra%%e /n (our Ho#"ital
8avid 9ood 'A&)
$aturday, 7th May 2011 / Venue: Conference Hall 3, Level 3
SYMPOSIUM #" CONGENITAL CARDIOLOGY 1: HYPERTROPHIC
CARDIOMYOPATHY
0!:00 10:30
Chair"er#on#: 1yu6i <ohara ',-) / Cal2ir $in0h '/<)
$3?.1 ;enetic# of HCM
Ma#a+a@u (a%a0i#hi ',-)
$3?.2 Clinical 8eci#ion 3ree# in HCM: 1i#+ of $udden 8eath
:ahid *#la% *4an '-&)
$3?.3 Medical 3hera"y for HBCM
3#ui.Lieh H#u '39)
$3?.= 9hen to Con#ider *2lation/%yo%ecto%y
1ic+ <i#hi%ura 'A$)
SYMPOSIUM 24 GENERAL CARDIOLOGY 2
11:00 12:30
Chair"er#on#: *2dul 1a#hid *2dul 1ah%an 'M() / 1yu ,ae &ean '&1)
$2= .1 5vidence Ca#ed Medicine fro% Cench to Ced#ide 'concentratin0 on "re.
clinical and clinical #tudie#)
*lan Fon0 'M()
$2= .2 5vidence Ca#ed Medicine in "o"ulation.2a#ed #tudie# 'concentratin0 on
cardiova#cular e"ide%iolo0y)
3ai 5e $hyon0 '$;)
$2= .3 /ncor"oratin0 5vidence into ;uideline# 'the 2i00er "icture)
1al"h Crindi# 'A$)
SYMPOSIUM #1 SPECIAL LECTURE: CARDIOPULMONARY RESUSCITATION
TODAY
16:00 17:30
Chair"er#on#: Mahendran &autha%an 'M() / *h%ad &hairuddin 'M()
$31.1 Ma6or chan0e# in 2010 CL$ 0uideline#
1ayney *@%i 'M()
$31.2 5vidence 2ehind Ma6or Chan0e# in *CL$
Li% $4ee Han '$;)
$31.= $harin0 3eachin0 eG"erience F challen0e#
/) <ational Heart /n#titute . *@hari 1o#%an 'M()
//) Aniver#ity Malaya Medical Centre . Chee &o+ Han 'M()

HO! TO SESSION 11 CLINICAL CARDIOLOGY 1
17:30 18:30
Chair"er#on#: 1a%e#h $in0h 'M() / *%al &u%ar Canar6ee '/<)
H311.1 3rou2le $hootin0 in /*C-
3an Huay Chee% '$;)
H311.2 Ho4 to u#e "ul%onary artery floatation catheter
$harifah $uraya 'M()
$aturday, 7th May 2011 / Venue: CanEuet Hall, Level 3
SYMPOSIUM 1( ENDOVASCULAR THERAPEUTICS 1: CRITICAL LIM
ISCHEMIA
0!:00 10:30
Chair"er#on#: 3a+aa+i /##hi+i ',-) / $eun0 ,in Bh'&1)
$1!.1 Critical Li%2 /#chae%ia: Fro% Claudication 3o ;an0rene . 9hy 8o 9e &ee"
Mi##in0 3he%I
(o#hio+i (o+oi ',-)
$1!.2 Multidi#ci"linary *""roach For Critical Li%2 /#chae%ia: /# /t Fea#i2leI
-aul &ao '39)
$1!.3 $tate of 3he *rt Lo4er Li%2 /ntervention
<eil $tric+%an 'A$)
3 Ca#e -re#entation# '10 Min# 5ach) 3 Forei0n 8ele0ate# 3o -re#ent Ca#e#
SYMPOSIUM 20 JOINT SYMPOSIUM 1: AMERICAN SOCIETY OF PREVENTIVE
CARDIOLOGY AT APSC - CHALLENGES AND OPPORTUNITY: OESITY AND
DIAETES IN ASIA
11:00 12:30
Chair"er#on#: Chin $@e -ia4 'M() / Hiro#ut0o Ae#hi%a ',-)
$20.1 B2e#ity, 8ia2ete# and Cardiova#cular 8i#ea#e: 5"ide%iolo0y and
;uideline# for Mana0e%ent of Cardio%eta2olic 1i#+#
<athan 9on0 'A$)
$20.2 3he Chan0in0 -attern of Cardia2e#ity in *#ia -acific: /ndication and
-revention
,uliana Chan 'H&)
$20.3 1i#+ *##e##%ent and $creenin0 for *thero#clero#i# in Meta2olic $yndro%e
and 8ia2ete#: 9hatK# 3he Ce#t 9ayI
1ody $y '-H)
OEHRINGER INGELHEIM SATELLITE LUNCH SYMPOSIUM
A PARADIGM SHIFT IN ORAL ANTICOAGULANTS FOR STRO%E PREVENTION
IN ATRIAL FIRILLATION $ LATEST UPDATE
12:30 1=:00
12:30 12:=0 B"enin0 1e%ar+# and /ntroduction 2y Chair"er#on
1a@ali B%ar 'M()
12:=0 13:20 * -aradi0% $hift in Bral *nticoa0ulant# for $tro+e -revention in
*trial Fi2rillation Late#t A"date
;re0ory Li" 'A$)
13:20 13:30 8i#cu##ion
SYMPOSIUM 2' CARDIAC SURGERY 1: NON-ISCHEMIC MITRAL
REGURGITATION
1=:00 1?:30
Chair"er#on#: -aneer#elva% / Hi#ayo#hi $u%a ',-)
$28.1 *##e##%ent of Valve $everity
Fau#to -into '-3)
$28.2 /ndication and 3i%in0
Chee 3ec+ $eon0 '$;)
$28.3 Mitral Valve 'MV) 1e"air
*ntonio Calafiore '$*)
SYMPOSIUM #0 CARDIAC IMAGING #: IMAGING IN RIS% STRATIFICATION
OF CHALLENGING PATIENTS
16:00 17:30
Chair"er#on#: 1ahal Mohd (u#off 'M() / *%al &u%ar Caner6ee '/<)
$30.1 *#y%"to%atic 8ia2etic# *nd C*8: $hould 9e 3e#t *nd 9hat /# 3he Ce#t
3e#tI
3ho%a# Mar4ic+ '*A)
$30.2 *#y%"to%atic -atient# 4ith Hi0h Coronary Calciu%: 9hat to 8o <eGtI
$a%uel 9ann 'A$)
$30.3 <on /nva#ive 3e#tin0 For C*8 /n 3he -hy#ically Challen0ed -atient: 9hat /#
*vaila2leI
3ho%a# Mar4ic+ '*A)
HO! TO SESSION ( ARRHYTHMIA 4
17:30 18:30
Chair"er#on#: Muha%%ad Muna4ar '/8) / $atchana -u%"rue0
H3!.1 3rou2le#hootin0 in -ace Ma+er
CJ <ara%#inhan '/<)
H3!.2 3rou2le#hootin0 in /C8
Vincent -aul '*A)
H3!.3 3rou2le#hootin0 in C13
(u Cheu+ Man 'H&)
$aturday, 7th May 2011 / Venue: Callroo% 1, Level 3
PLENARY " HYPERTENSION 2
08:00 0!:00
Chair"er#on#: *@ani Mohd 8aud 'M() / Cryan 9illia%# 'A&)
-?.1 3ran#lational Medicine.*""lyin0 3he 5vidence to B"ti%i#e Mana0e%ent of
Hy"erten#ion
*2dul 1a#hid *2dul 1ah%an 'M()
-?.2 Half a Century of Hydrochlorothia@ide Fact#, Fad#, Fiction and
Follie#
Fran@ Me##erli 'A$)
SYMPOSIUM 1' HYPERTENSION #: END ORGAN DAMAGE IN
HYPERTENSION
0!:00 10:30
Chair"er#on#: $aifur 1oh%an 'M() / 3ian0 $oon 9ee 'M()
$18.1 Hy"erten#ive Heart 8i#ea#e Mechani#%# and 3reat%ent B"tion#
1 -ra2a#h Chand Manoria '/<)
$18.2 Ho4 Can 9e Ce#t -re#erve &idney Function /n Bur Hy"erten#ive -atient#I
;ha@ali *h%ad 'M()
$18.3 Hy"erten#ion *nd 8e%entia
-ar+ ,eon0 Cae '&1)
SYMPOSIUM 1" CARDIAC REHA 2: CARDIAC REHAILITATION IN SPECIAL
POPULATIONS
11:00 12:30
Chair"er#on#: *i@ai *@an 'M() / Vi#al &antaratana+ul '3H)
$1?.1 Con0e#tive Heart Failure 1eha2ilitation: Current -er#"ective#
3an $4ee (a4 '$;)
$1?.2 -hy#ical *ctivity *nd 5Gerci#e For 3he 5lderly
Lydia Latiff 'M()
$1?.3 1eha2ilitation Con#ideration# For -atient# 9ith *rrhyth%ia# and 8evice#
(oichi ;oto ',-)
SYMPOSIUM 2" HYPERTENSION 4: MANAGEMENT OF HYPERTENSION
1=:00 1?:30
Chair"er#on#:
$2?.1 /ncrea#in0 Curden of Hy"erten#ion in the *#ia.-acific 1e0ion 8efinin0 the
Challen0e#
3refor Mor0an '*A)
$2?.2 <on -har%acolo0ical Mana0e%ent of Hy"erten#ion
86an00an $ar0o4o '/8)
$2?.3 Control of Hy"erten#ion in 8evelo"in0 Countrie# 9hat $trate0ie# May
9or+I /# $in0le -ill Co%2ination the 9ay For4ardI
*@hari 1o#%an 'M()
SYMPOSIUM ## CARDIAC REHA #: THE ART AND SCIENCE OF
COMPLIANCE
16:00 17:30
Chair"er#on#: Cahanordin ,aafar 'M() / Lydia Latiff 'M()
$33.1 Carrier# to Cardiac 1eha2ilitation -artici"ation: Ho4 to $ucceedL
*ntonio $J $i2ulo '-H)
$33.2 Ander#tandin0 Health Cehaviour Chan0e#J Hel"in0 -atient# 3o Hel"
3he%#elve#
,ac+ Le4in 'A$)
$33.3 1eturnin0 3o 9or+: 9hat *re the /##ue#I
3an $4ee (a4 '$;)
HO! TO SESSION 1# SPECIAL TOPIC #
17:30 18:30
Chair"er#on: Li% 3ec+ Bnn 'M()
H3 13.1 Ho4 to 9rite Clinical -a"er# *nd ;et /t -u2li#h
;oh -i+ -in 'M() / &ula#e0aran 'M()
$aturday, 7th May 2011 / Venue: Callroo% 2, Level 3
PLENARY 4 VALVULAR HEART DISEASE 1
08:00 0!:00
Chair"er#on#: 1a6a *%in 1a6a Mo+htar 'M() / *nil &u%ar '/<)
-=.1 5valuation of /#che%ic M1 and the 3i%in0 of /ntervention
1ic+ <i#hi%ura 'A$)
-=.2 3echniEue of /#che%ic MV 1e"air
*ntonio Calafiore '$*)
SYMPOSIUM 16 CLINICAL CARDIOLOGY 1: ACS - A NE! HORI*ON IN
THERAPY
0!:00 10:30
Chair"er#on#: :ur+urnai (u#off 'M() / Ca%2an0 Cudi $i#4anto '/8) / Bteh Ha%ad
Ha%di 'M() / Moha%%ad Hani+i <i+ Moha%%ad '/8)
$16.1 *re *ll *8-.*nta0oni#t *nti"latelet# the $a%eI
1o2aayah :a%2ahari 'M()
$16.2 3he <e4 Bral *nticoa0ulant# in *C$ Ceyond Conventional 8ual
*nti"latelet 3hera"y
&en &o@u%a ',-)
$16.3 Cleedin0, the -rice to -ay
$teven VJ Manou+ian 'A$)
SYMPOSIUM 21 CLINICAL CARDIOLOGY 2: FRONTIERS IN STEMI
11:00 12:30
Chair"er#on#: Bteh Ma#+on 'M() / Mano6+u%ar 1ohit '$;) / Bteh /+a Fai@ura Mohd
<or 'M() / &i% 5un0 ,u '&1)
$21.1 *nti"latelet# . B"ti%i#in0 <et Clinical Cenefit Calance of 5fficacy and $afety
Fady Michel 3urEuieh 'LC)
$21.2 -ri%ary -C/ in $35M/ *#ian -acific -er#"ective
3an Huay Chee% '$;)
$21.3 B"ti%i#in0 3reat%ent $trate0ie# in -o#t.Ly#i# $35M/
,a%e# Ca%eron '*A)
SYMPOSIUM 2( PREVENTIVE CARDIOLOGY #: ASYMPTOMATIC AND
SUCLINICAL CORONARY DISEASE
1=:00 1?:30
Chair"er#on#: $uren 3hurai#in0ha% 'M() / ,a%e# Ca%eron '*A)
$2!.1 8o Cio%ar+er# *nd $creenin0 For $u2clinical *thero#clero#i# /%"rove
Cardiova#cular 8i#ea#e 1i#+ -redictionI
<athan 9on0 'A$)
$2!.2 /nte0ratin0 8ata fro% -laEue 1e0re##ion $tudie# into CV -revention
Choo ;i% Hooi 'M()
$2!.3 *nato%ical /%a0in0 v#J Functional 3e#tin0 for *#y%"to%atic Coronary
8i#ea#e.9hich i# CetterI
3an $4ee (a4 '$;)
SYMPOSIUM #4 JOINT SYMPOSIUM #: APSC-!HF TOACCO CONTROL:
!HAT+S NE! AND SMO%ING HOT&
16:00 17:30
Chair"er#on#: 8avid Hue+ 'M() / &athryn 3au2ert 'A$)
$3=.1 9hat 8o 9e 8o *2out 3he $%o+in0 5"ide%ic /n *#iaI
$idney $%ith 'A$)
$3=.2 Current 5G"erience Fro% 3he 5A1B*C3/B< .-LA$ $tudy *nd Bther
Le##on# Learnt Fro% 3he A&
8avid 9ood 'A&)
$3=.3 Current 3reat%ent B"tion# For <icotine 8e"endence
Moha%ed Hani+i <i+ Moha%ed 'M()
$3=.= $%o+ele## 3o2acco *nd -a##ive $%o+in0: 9hat *re 3he 1eal
Con#eEuence#
1a@a+ 'M() / *ru%u0a% 'M()
HO! TO SESSION 14 SPECIAL TOPIC 4
17:30 18:30
H3 1=.1 Ho4 to /nter"ret Clinical -a"er
*%ar $in0h 'M()
$aturday, 7th May 2011 / Venue: -lenary 3heatre, Level 3
!OMEN AND HEART DISEASE SYMPOSIUM
0!:00 10:30
HEART DISEASE IN PREGNANCY
Chair"er#on#: $antha &u%ari 'M() / &athyrn 3au2ert 'A$)
9H1.1 -reecla%"#ia and Future Cardiova#cular 8i#ea#e 1i#+
<anette 9en0er 'A$)
9H1.2 Hy"erten#ion and Heart failure in -re0nancy
5leanor Lo"e@ '-H)
9H1.3 -eri"artu% Cardio%yo"athy
;ane#6a M Hari%urti '/8)
11:00 12:30
!OMEN AND CAD
Chair"er#on#: 8e4i 1a%a#a%y 'M() / *+ira Mat#u%ori ',-)
9H2.1 3he Fe%inine Face Bf Heart 8i#ea#e, 9hat do 4e &no4 *2out *n0ina in
9o%enI
<anette 9en0er 'A$)
9H2.2 *##e##%ent of che#t "ain# and Mana0e%ent of C*8 in 4o%en
;oh -in0 -in0 '$;)
9H2.3 -revention of Heart 8i#ea#e in 9o%en
&athryn 3au2ert 'A$)
1=:00 1?:30
!OMEN AND HEALTH
Chair"er#on#: Lee Chuey (an 'M() / 8r ;oh -in0 -in0 '$;)
9H3.1 Hy"erten#ion, 8ia2ete# and 8y#li"ide%ia in 9o%en : /# treat%ent different
fro% MenI
Bn0 Mei Lin0 'M()
9H3.2 Calciu%, Vit 8 deficiency and 4o%enD# Health
,eya%alar 1a6adurai 'M()
9H3.3 3he *%erican Heart *##ociation 2011 ;uideline# for Cardiova#cular
8i#ea#e "revention in 9o%en . /nternational
*""lica2ility
<anette 9en0er 'A$)
16:00 17:30
PERSPECTIVES ON !OMEN+S HEART HEALTH IN THE ASIA PACIFIC REGION
Chair"er#on: 1o2ayaah :a%2ahari 'M()
1) 5leanor * Lo"e@ '-H), -re#ident of -hili""ine Heart *##ociation
2) *nna Alfah 1aha6oe '/8), -re#ident of /ndone#ia Heart *##ociation
3) ;oh -in0 -in0 '$;), 1e"re#entative of $in0a"ore Cardiac $ociety
=) ,eya%alar 1a6adurai 'M()
?) (in0noi A2olde6"rachara+ '3H), -re#ident of 3he Heart *##ociation of 3hailand
$unday, 8th May 2011 / Venue: Conference Hall 2, Level 3
PLENARY ( HEART FAILURE 2
08:00 0!:00
Chair"er#on#: Bteh Ma#+on 'M() / Cyun0 Hee Bh '&1)
-!.1 $te% Cell thera"y for i#che%ic heart di#ea#e
Chin $@e -ia4 'M()
-!.2 ;ene and $te% Cell thera"y in Heart Failure
$andee" $eth '/<)
SYMPOSIUM 26 JOINT SYMPOSIUM 2
0!:00 . 10:30
Chair"er#on#: <0 9ai &iat / -ra#art Laothavorn '3H)
$26.1 *-$C . *CC ,oint $y%"o#iu%
1) 1i#+ $tratification of $udden Cardiac *rre#t
,ac+ Le4in
2) Mana0e%ent of Coronary *rtery 8i#ea#e in the Very 5lderly
1al"h Crindi#
3) 3*V/ . Malay#ia -er"ective
1o#li 'M()

SYMPOSIUM 41 MEET !ITH THE E)PERTS 2 $ STALE ANGINA
11:00 12:30
$=1.1 Controver#ie# in Mana0e%ent Ca#e Ca#ed *""roach
*%in *riff 'M() / $teven VJ Manou+ian 'A$)
-aneli#t:
1) $an0 Hyun /h%'&1)
2) Chian0 Fu 3ien '39)
3) $ree 1a%an 'M()
$unday, 8th May 2011 / Venue: Conference Hall 3, Level 3
SYMPOSIUM #' GENERAL CARDIOLOGY 2: SUDDEN DEATHS IN THE
YOUNG ADULTS
0!:00 10:30
Chair"er#on#: -ha% <hu Hun0 'V<) / /%ran
$38.1 $C8 in (oun0 *dult# *#ian -acific -er#"ective
(a#h Lo+hand4ala '/<)
$38.2 C*8 /n 3he (oun0 *dult#
$u+%an 3 -utra
$38.3 -revention of $C8 /n 3he (oun0 *dult# *re 9e 8oin0 5nou0hI
Mohan <air '/ndia)
SYMPOSIUM 42 GENERAL CARDIOLOGY #: PULMONARY HYPERTENSION
11:00 12:30
Chair"er#on#: *#hari (unu# 'M() / &evin ,o#e"h 'M()
$=2.1 -ul%onary Hy"erten#ion <e4 Cla##ification and 8efinition
Hyon0 <ic+ &/M 'A$)
$=2.2 A"date on -atho0ene#i# of -ul%onary *rterial Hy"erten#ion
8avid Che4 'M()
$=2.3 $creenin0 and 8ia0no#i# of -*H: 8o 9e 1eally <eed 1HC
,a%e# (i" '$;)
$=2.= Mana0e%ent of -ul%onary Hy"erten#ion
Hyon0 <ic+ &/M 'A$)
$unday, 8th May 2011 / Venue: CanEuet Hall, Level 3
PLENARY ' ARRHYTHMIA 2: PREVENTION OF STRO%E IN AF
08:00 0!:00
Chair"er#on#: *nthony &in0 / Muha%%ad (a%in
-8.1 <e4 *nti.Coa0ulant#: 9ill 4e #ay 0ood 2ye to 9arfarinI
;re0ory Li" 'A&)
-8.2 *""enda0e clo#ure device#
1a@ali B%ar 'M()
SYMPOSIUM #7 ENDOVASCULAR THERAPEUTICS 2: SUPRA AORTIC
ARTERY SYMPOSIUM
0!:00 10:30
Chair"er#on#: 3a+aa+i /##hi+i ',-) / *lo+ 1an6an '/<)
$37.1 /ntervention for $u2clavian *rtery $teno#i#M Ho4 / do itI
(o#hio+i (o+oi ',-) Ca#e "re#entation
$37.2 -lu%2in0K For Carotid *rtery $teno#i#: Can 9e $tent *ll Le#ion#I
<eil $tric+%an 'A$) Ca#e "re#entation
$37.3 Carotid *rtery $teno#i#: * $ur0eonK# Vie4"oint
Hanafiah Harunara#hid 'M()
2 Ca#e -re#entation# '10 %in 5ach) 3 Forei0n 8ele0ate# 3o -re#ent Ca#e#
SYMPOSIUM 40 CARDIAC IMAGING 4: CARDIACT CT-STILL HOT, NE! -
CONTROVERSIAL
11:00 . 12:30
Chair"er#on#: Choo ;i% Hooi 'M() / *2ani A"adhyaya '<-)
$=0.1 Current *""lication# Bf Cardiac C3
3an $4ee (a4 '$;)
$=0.2 Cardiac C3 in Con0enital Heart 8i#ea#e
Martin 9on0 'M()
$=0.3 1adiation /##ue# in Cardiac C3
;re0ory 3ho%a# 'A$)
$unday, 8th May 2011 / Venue: Callroo% 1, Level 3
SYMPOSIUM #6 HYPERTENSION ": MANAGEMENT ISSUES IN
HYPERTENSION
0!:00 10:30
Chair"er#on#: 3refor Mor0an / *@ani
$36.1 -re.Hy"erten#ion /# 3here 5nou0h 5vidence to 3reatI
*2dul 1a#hid *2dul 1ah%an 'M()
$36.2 Hy"erten#ion at 3he 5Gtre%e Bf *0e Ho4 *00re##ive 8o 9e Have 3o Ce
Cryan 9illia%# 'A&)
$36.3 5%er0in0 $trate0ie# for Mana0e%ent of CV ri#+ Factor# in Hy"erten#ion
;ary ,ennin0# '*A)
SYMPOSIUM 4# HEART FAILURE AND ATRIAL FIRILLATION
11:00 12:30
Chair"er#on#: Mohan <air / $urinder
$=3.1 -atho"hy#iolo0y of *trial Fi2rillation in HF
(a#h Lo+hand4ala '/<)
$=3.2J 8ru0 3reat%ent of *trial Fi2rillation /n HF
Muha%%ad Muna4ar '/8)
$=3.3 1ole of C13 in HF 4ith *F
(u Cheu+ Man 'H&)
$unday, 8th May 2011 / Venue: Callroo% 2, Level 3
PLENARY 7 PREVENTIVE CARDIOLOGY #: CARDIOVASCULAR DISEASE
PREVENTION FOR THE NE! DECADE
08:00 0!:00
Chair"er#on#: 5%ily 3an 'M() / Mri0endra -andey '<-)
-7.1 Challen0e# and B""ortunity for -reventive Cardiolo0y: Le##on# fro% 5uro"e
8avid 9ood 'A&)
-7.2 Challen0e# and B""ortunity for -reventive Cardiolo0y: *#ia -acific
-er#"ective
8avid Hue+ 'M()
SYMPOSIUM #( JOINT SYMPOSIUM ": EAPCR AT APSC 2011
0!:00 10:30
Chair"er#on#: Lie4 Houn0 Can0 'M() / 5u0une 1eye# '-H)
$3!.1 5A1B*C3/B<: * Cench%ar+ For Modern -reventive Cardiolo0y Care
8avid 9ood 'A&)
$3!.2 $"oilt For ChoiceL CV 1i#+ $core# *nd *""lica2ility 3o 3he *#ia.-acific
-o"ulation
3ai 5 $hion0 '$;)
$3!.3 3he N-oly"illO: 5#ta2li#hin0 /t# 1ole /n -reventive Cardiolo0y
$idney $%ith 'A$)
SYMPOSIUM 44 PREVENTIVE CARDIOLOGY ": REAL !ORLD ISSUES IN
CARDIOVASCULAR DISEASE PREVENTION
11:00 12:30
Chair"er#on#: *lan Fon0 'M() / -eter 3in0 '$;)
$==.1 For *#ian -alate#: Challen0e# /n Healthy 5atin0
Mary 5a#a4 'M()
$==.2 $alt 1eduction *nd Cardiova#cular 8i#ea#e: Fro% 5vidence 3o 9orld4ide
/%"le%entation
3refor Mor0an '*A)
$==.3 Vita%in# and $u""le%ent#: 9hat 9or+# '*nd 9hat 8oe#nKtL)
5u0ene 1eye# '-H)